Time to Treatment Intensification in Patients Receiving DPP4 Inhibitors Versus Sulfonylureas as the First Add-On to Metformin Monotherapy: A Retrospective Cohort Study

• Main Authors: Giuseppe Roberto (Author), Anna Girardi (Author), Francesco Barone-Adesi (Author), Alessandro Pecere (Author), Valentina Ientile (Author), Claudia Bartolini (Author), Roberto Da Cas (Author), Stefania Spila-Alegiani (Author), Carmen Ferrajolo (Author), Paolo Francesconi (Author), Gianluca Trifirò (Author), Elisabetta Poluzzi (Author), Fabio Baccetti (Author), Rosa Gini (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: To verify whether, in patients on metformin (MET) monotherapy for type 2 diabetes (T2D), the add-on of a dipeptidyl peptidase inhibitor (DPP4i) compared to a sulfonylurea (SU) can delay the time to the subsequent treatment intensification (TI).Methods: Population-based administrative dat...